The shortening of leukocyte telomere length relates to DNA hypermethylation of LINE-1 in type 2 diabetes mellitus
- PMID: 29088760
- PMCID: PMC5650315
- DOI: 10.18632/oncotarget.18167
The shortening of leukocyte telomere length relates to DNA hypermethylation of LINE-1 in type 2 diabetes mellitus
Abstract
Background: We aim to investigate the cross-talking of leukocyte telomere length (LTL) and DNA methylation of LINE-1 in type 2 diabetes mellitus (T2DM).
Results: LTL (ratio of the copy number of telomere [T] repeats to that of a single [S] gene) was significantly shortened in T2DM compared with controls (0.94 ± 0.41 vs. 1.14 ± 0.48, P < 0.001), and decreased steadily with age in both controls and T2DM. Conversely, significant increase of LINE-1 DNA methylation was found in T2DM compared with controls (49.60 ± 14.55 vs. 37.81 ± 9.07, P < 0.001). Moreover, age, HbA1c, and LINE-1 methylation ratio were stably negatively related with LTL after multi-adjustment. Shorter LTL was associated with an increased risk of T2DM [adjusted OR (95% CI) = 2.458 (1.192, 5.070), P = 0.015], while lower LINE-1 DNA methylation levels could reduce the risk of T2DM [adjusted OR (95% CI) = 0.189 (0.089, 0.400), P < 0.001].
Materials and methods: We performed a hospital-based case-control study of 205 T2DM patients and 213 subjects of healthy control with sex and age matched. LTL and DNA methylation of LINE-1 was measured by quantitative PCR and quantitative methylation-specific PCR (qMSP), respectively.
Conclusions: Our research demonstrates the association between shorter LTL and LINE-1 hyper-methylation in Chinese T2DM patients. These findings suggest that shorter LTL might be associated with T2DM in a manner dependent of epigenetic level.
Keywords: DNA methylation; LINE-1; glycated hemoglobin; leukocyte telomere length; type 2 diabetes mellitus.
Conflict of interest statement
CONFLICTS OF INTEREST The authors declare no competing financial interests.
Figures
Similar articles
-
Systemic inflammation, oxidative damage and neurocognition predict telomere length in a transdiagnostic sample stratified by global DNA methylation levels.Sci Rep. 2024 Jun 7;14(1):13159. doi: 10.1038/s41598-024-62980-6. Sci Rep. 2024. PMID: 38849401 Free PMC article.
-
Association of leukocyte telomere length with non-alcoholic fatty liver disease in patients with type 2 diabetes.Chin Med J (Engl). 2019 Dec 20;132(24):2927-2933. doi: 10.1097/CM9.0000000000000559. Chin Med J (Engl). 2019. PMID: 31809318 Free PMC article.
-
Association of leukocyte telomere length with metabolic syndrome in type 2 diabetes mellitus.J Res Med Sci. 2021 Jul 31;26:43. doi: 10.4103/jrms.JRMS_793_20. eCollection 2021. J Res Med Sci. 2021. PMID: 34484375 Free PMC article.
-
Electrocardiogram QRS duration and associations with telomere length: A cross-sectional analysis in Australian rural diabetic and non-diabetic population.J Electrocardiol. 2017 Jul-Aug;50(4):450-456. doi: 10.1016/j.jelectrocard.2017.02.010. Epub 2017 Feb 20. J Electrocardiol. 2017. PMID: 28249683
-
Telomeres and cardiovascular disease risk: an update 2013.Transl Res. 2013 Dec;162(6):371-80. doi: 10.1016/j.trsl.2013.05.004. Epub 2013 Jun 7. Transl Res. 2013. PMID: 23748031 Review.
Cited by
-
Telomeres and Age-Related Diseases.Biomedicines. 2021 Sep 27;9(10):1335. doi: 10.3390/biomedicines9101335. Biomedicines. 2021. PMID: 34680452 Free PMC article. Review.
-
Influence of DNA Methylation on Vascular Smooth Muscle Cell Phenotypic Switching.Int J Mol Sci. 2024 Mar 8;25(6):3136. doi: 10.3390/ijms25063136. Int J Mol Sci. 2024. PMID: 38542110 Free PMC article. Review.
-
Telomere shortening associates with elevated insulin and nuchal fat accumulation.Sci Rep. 2020 Apr 22;10(1):6863. doi: 10.1038/s41598-020-63916-6. Sci Rep. 2020. PMID: 32322021 Free PMC article. Clinical Trial.
-
The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus.Clin Epigenetics. 2020 Jul 11;12(1):104. doi: 10.1186/s13148-020-00896-4. Clin Epigenetics. 2020. PMID: 32653024 Free PMC article. Review.
-
Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications.Front Endocrinol (Lausanne). 2018 Dec 4;9:744. doi: 10.3389/fendo.2018.00744. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30564199 Free PMC article. Review.
References
-
- Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J, Stengard J, Kesaniemi YA. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia. 1992;35:1060–7. - PubMed
-
- You NC, Chen BH, Song Y, Lu X, Chen Y, Manson JE, Kang M, Howard BV, Margolis KL, Curb JD, Phillips LS, Stefanick ML, Tinker LF, et al. A prospective study of leukocyte telomere length and risk of type 2 diabetes in postmenopausal women. Diabetes. 2012;61:2998–3004. doi: 10.2337/db12-0241. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources